{
    "clinical_study": {
        "@rank": "139370", 
        "arm_group": {
            "arm_group_label": "MRI, Neuropsychological testing", 
            "arm_group_type": "Other"
        }, 
        "brief_summary": {
            "textblock": "The main purposes with this trial is to investigate the potential of MRI with diffusion and\n      blood volume,  flow  in brain  to diagnose and to measure treatment effects in patients with\n      intracranial tumors, especially gliomas and metastases in a prospective trial, to evaluate\n      the possibilities to individually adjusted treatment in this category of patients depending\n      on treatment outcomes measured by MRI, to perform clinical follow up in connection with MRI\n      to evaluate a correlation and to perform testing of cognitive ability before, during, and\n      after treatment and to investigate if given treatment causes any decrease in the patients\n      habitual state."
        }, 
        "brief_title": "Treatment Effects Inclusive Cognitive Impact and Possibilities to Individually Adjusted Treatment in Patients With Intracranial Tumors With Clinical, Neuropsychological and Imaging Parameters", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Intracranial Tumor", 
        "condition_browse": {
            "mesh_term": "Brain Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 18 years or older\n\n          -  Suspected primary brain tumor, verified glioblastoma or non surgically treated\n             metastases from solid tumor\n\n          -  Increasing MRI changes in patients with previous verified glioblastoma\n\n          -  Be able to speak Swedish without difficulties (because of the neuropsychological\n             investigations)\n\n          -  Written informed concent\n\n        Exclusion Criteria:\n\n          -  Unability to perform MRI"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "150", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 23, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01674582", 
            "org_study_id": "Version1.0"
        }, 
        "intervention": {
            "arm_group_label": "MRI, Neuropsychological testing", 
            "description": "MRI at timepoints given above, neuropsychological testing after surgery, but before radiotherapy or chemotherapy.\nNeuropsychological testing month 3 during treatment. Neuropsychological testing after 1 year. Neuropsychological testing after 2 years.", 
            "intervention_name": "MRI, neuropsychological evaluation, blood sampling", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Glioma", 
            "Brain tumors", 
            "Brain metastases", 
            "MRI", 
            "Cognitive measurement", 
            "Neuropsychological evaluation", 
            "DW-MRI", 
            "P-MRI", 
            "MRS"
        ], 
        "lastchanged_date": "April 25, 2014", 
        "location": {
            "contact": {
                "email": "danielle.vanwesten@skane.se", 
                "last_name": "Danielle van Westen, MD, PhD", 
                "phone": "+46 46"
            }, 
            "contact_backup": {
                "email": "sara.kinhult@med.lu.se", 
                "last_name": "Sara Kinhult, MD, PhD", 
                "phone": "+46 46 17 75 20"
            }, 
            "facility": {
                "address": {
                    "city": "Lund", 
                    "country": "Sweden", 
                    "zip": "221 85"
                }, 
                "name": "Lund University Hospital"
            }, 
            "investigator": {
                "last_name": "Danielle van Westen, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "1", 
        "official_title": "Treatment Effects Inclusive Cognitive Impact and Possibilities to Individually Adjusted Treatment in Patients With Intracranial Tumors With Clinical, Neuropsychological and Imaging Parameters.", 
        "overall_contact": {
            "email": "danielle.vanwesten@skane.se", 
            "last_name": "Danielle van Westen, MD, PhD", 
            "phone": "+46 46 17 30 03"
        }, 
        "overall_contact_backup": {
            "email": "sara.kinhult@med.lu.se", 
            "last_name": "Sara Kinhult, MD, PhD", 
            "phone": "+46 46 17 75 20"
        }, 
        "overall_official": {
            "affiliation": "Sk\u00e5ne University Hospital-Lund", 
            "last_name": "Danielle van Westen, MD. PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sweden: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Early prediction of treatment response based on MRI parameters.", 
            "safety_issue": "No", 
            "time_frame": "Three weeks compared to baseline."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01674582"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Neuropsychological testing to evaluate the correlation between MRI results and neuropsychological status in participating patients. This applies for 80 patients of 150 of the patient population.", 
            "measure": "Neuropsychological function.", 
            "safety_issue": "No", 
            "time_frame": "Month 3, 12, and 18 compared to baseline"
        }, 
        "source": "Lund University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Lund University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}